STVN Stevanato Group S.p.A.

15.93USD+3.71%Mkt Cap: 4.35B USDP/E: 27.00

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South A…

Insiders, last 90 days1 buy
Institutional holders20 on file

Key Statistics

Company
Market Cap4.35B USD
Enterprise Value4.55B USD
Revenue (TTM)1.37B USD
Gross Profit377.16M USD
Net Income (TTM)153.38M USD
Revenue/Share5.01 USD
Last Price15.93 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees6.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)27.00
P/E (Forward)22.00
PEG1.90
EV/EBITDA14.76
EV/Revenue3.32
P/S3.49
P/B2.43
EPS (TTM)0.65 USD
EPS (Forward)0.79 USD
52W Range
12.0632% of range24.01
52W High24.01 USD
52W Low12.06 USD
Profitability
Gross Margin28.99%
Oper. Margin17.95%
EBITDA Margin24.70%
Profit Margin11.79%
ROE9.41%
ROA5.50%
ROIC8.06%
ROCE9.90%
Growth
Revenue Growth7.60%
Earnings Growth15.40%
Cash Flow & Leverage
Operating CF313.77M USD
CapEx (TTM)301.66M USD
FCF Margin-5.23%
FCF Yield-1.64%
Net Debt389.82M USD
Net Debt/EBITDA1.15
Net Debt/FCF—
Balance Sheet
Debt/Equity0.32
Current Ratio1.73
Quick Ratio1.18
Book Value/Sh7.19 USD
Cash/Share0.47 USD
Dividends
Fwd Div Rate0.06 USD
Trail. Div Rate0.00 USD
Div. Yield0.40%
5Y Avg Yield0.26%
Payout Ratio10.59%
Ex-Div DateJun 11, 2026
Pay DateJul 29, 2026
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.46 USD
Upside (mean)+22.1%
Target Range16.00 USD – 25.00 USD
16.00+22.1% to mean25.00
# Analysts12
Ownership
Shares Out.49.83M
Float49.00M
Insiders1.87%
Institutions102.36%
Short Interest
Short Ratio2.5d
Short % Float1.81%
Short % Out.0.32%
Shares Short886.27K
Short (prev mo.)1.09M
Technical
SMA 5019.05 (-16.4%)
SMA 20017.92 (-11.1%)
Beta0.80
S&P 52W Chg12.08%
Avg Vol (30d)995.76K
Avg Vol (10d)2.10M
Technical Indicators
RSI (14)45.0
MACD-1.0915
MACD Signal-1.2958
MACD Hist.+0.2043
BB Upper21.66 USD
BB Middle16.28 USD
BB Lower10.90 USD
BB Width66.12%
ATR (14)1.043 USD
Vol Ratio (20d)0.38x

About Stevanato Group (NYSE: STVN)

›

Stevanato Group (NYSE: STVN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 6,010 employees.

The shares were at 15.93 USD on 19 November 2026, down 23.3% over 52 weeks. Its 52-week range is 12.06 USD to 24.01 USD: the price is 33.7% below the high and 32.1% above the low.

At a market capitalisation of 4.35B USD, it trades at 27.0 times trailing earnings and 22.0 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 45% for STVN. It pays a dividend yielding 0.40% (it pays out 11% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Stevanato Group reports return on equity of 9.4%, an operating margin of 18.0% and revenue up 7.6% year over year.

Its debt exceeds its cash by 355.42M EUR, a debt-to-equity ratio of 0.32. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 19.46 USD is 22.1% above the current price. The next earnings report is expected on 3 March 2027.